Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
Sponsor: Yale University
Summary
Randomized double-blind placebo-controlled crossover study design
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-07-24
Completion Date
2028-03-01
Last Updated
2024-10-08
Healthy Volunteers
No
Conditions
Interventions
Ammonium Chloride
Participants will be randomized to receive either ammonium chloride or placebo. Participants will receive randomized drug in combination with IV bumetanide, bendroflumethiazide, and amiloride. Following a washout period, participants will be crossed over to the alternate drug.
Placebo
Participants will be randomized to receive either ammonium chloride or placebo. Participants will receive randomized drug in combination with IV bumetanide, bendroflumethiazide, and amiloride. Following a washout period, participants will be crossed over to the alternate drug.
Locations (1)
Yale University
New Haven, Connecticut, United States